<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00184847</url>
  </required_header>
  <id_info>
    <org_study_id>ACAD</org_study_id>
    <nct_id>NCT00184847</nct_id>
  </id_info>
  <brief_title>Adenosine Receptors Influence Ischemia-Reperfusion Injury</brief_title>
  <official_title>Adenosine Receptor Involvement in Acute Ischemic Preconditioning of the Vascular Endothelium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <brief_summary>
    <textblock>
      Ischemic preconditioning is defined as the development of tolerance to ischemia-reperfusion
      injury by a previous short bout of ischemia resulting in a marked reduction in infarct size.
      This mechanism can be mimicked by several pharmacological substances such as acetylcholine
      and adenosine.

      To detect ischemia-reperfusion injury in humans in vivo Kharbanda et al. developed a method
      in which endothelial dysfunction represents the effects of ischemic preconditioning. This
      method, however, uses acetylcholine to measure endothelial function before and after forearm
      ischemia. We, the investigators at Radboud University, hypothesize that the use of
      acetylcholine in this model reduces ischemia-reperfusion injury. Therefore, we will compare
      this protocol with a protocol in which endothelial function is only measured after ischemia.
      We expect an increase in ischemia-reperfusion injury when endothelial function is only
      measured after the forearm ischemia.

      After determining the optimal method to measure ischemia-reperfusion injury of the vascular
      endothelium we will determine the effect of acute and chronic caffeine, an adenosine receptor
      antagonist, on ischemic preconditioning. With this study we expect to find that adenosine
      mimics ischemic preconditioning of the vascular endothelium. Moreover, we expect to find that
      acute caffeine intake reduces ischemia-reperfusion injury whereas chronic caffeine intake
      does not. This study will increase our knowledge about the mechanism of ischemic
      preconditioning and may also provide leads to exploit this endogenous protective mechanism in
      a clinical setting.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>March 2005</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentual increase in forearm blood flow ratio to three increment dosages of acetylcholine before forearm ischemia and within two hours after forearm ischemia</measure>
  </primary_outcome>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Ischemia-Reperfusion Injury</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetylcholine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>twenty minutes of forearm ischemia</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>three 5-minute periods of forearm ischemia</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>adenosine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>caffeine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerard Rongen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University Nijmegen Medical Centre/Department of Pharmacology and Toxicology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre/Department of Pharmacology and Toxicology</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J, MacAllister R. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation. 2001 Mar 27;103(12):1624-30.</citation>
    <PMID>11273988</PMID>
  </reference>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>March 27, 2008</last_update_submitted>
  <last_update_submitted_qc>March 27, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2008</last_update_posted>
  <keyword>acetylcholine</keyword>
  <keyword>adenosine</keyword>
  <keyword>caffeine</keyword>
  <keyword>ischemic preconditioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
    <mesh_term>Adenosine</mesh_term>
    <mesh_term>Acetylcholine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

